Improving the process of determining protein sequences using fluorescent labeling
Facilitating the Chemistry of Fluorosequencing
This study is testing a new way to look at proteins using special glowing markers, which could help scientists better understand and identify proteins in health and medical tests.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-11042715 on NIH RePORTER |
What this research studies
This research focuses on developing a new technique called fluorosequencing to enhance the analysis of protein sequences. By labeling amino acids with fluorescent markers and using advanced microscopy, the researchers aim to identify and sequence proteins one molecule at a time. This method allows for the analysis of complex mixtures of peptides in parallel, which could lead to more efficient and accurate protein sequencing. The research seeks to overcome current limitations in protein analysis methods, making it more accessible for various applications in health and diagnostics.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that require precise protein analysis, such as certain genetic disorders or cancers.
Not a fit: Patients with conditions that do not involve protein sequencing or those who are not undergoing diagnostic evaluations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the accuracy and efficiency of protein sequencing, leading to better diagnostic tools and treatments for various diseases.
How similar studies have performed: While the approach of using fluorescent labeling for protein sequencing is innovative, similar techniques have shown promise in other areas of genomics and diagnostics.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Anslyn, Eric V. — University of Texas at Austin
- Study coordinator: Anslyn, Eric V.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.